<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="brief-report" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">1662-4548</issn>
<issn pub-type="epub">1662-453X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27536211</article-id>
<article-id pub-id-type="pmc">4971013</article-id>
<article-id pub-id-type="doi">10.3389/fnins.2016.00351</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Psychiatry</subject>
<subj-group>
<subject>Perspective</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The Genetic Etiology of Tourette Syndrome: Large-Scale Collaborative Efforts on the Precipice of Discovery</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Georgitsi</surname>
<given-names>Marianthi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/304709/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Willsey</surname>
<given-names>A. Jeremy</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/338771/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mathews</surname>
<given-names>Carol A.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/248797/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>State</surname>
<given-names>Matthew</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/363450/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scharf</surname>
<given-names>Jeremiah M.</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/357774/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Paschou</surname>
<given-names>Peristera</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/33009/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Molecular Biology and Genetics, Democritus University of Thrace</institution>
<country>Alexandroupoli, Greece</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Medicine, Aristotle University of Thessaloniki</institution>
<country>Thessaloniki, Greece</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Psychiatry, University of California, San Francisco</institution>
<country>San Francisco, CA, USA</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Psychiatry, University of Florida School of Medicine</institution>
<country>Gainesville, FL, USA</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Departments of Neurology and Psychiatry, Massachusetts General Hospital, Harvard Medical School</institution>
<country>Boston, MA, USA</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: John Vijay Sagar Kommu, National Institute of Mental Health and Neurosciences, India</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Katerina Maniadaki, Technological Educational Institute of Athens, Greece; Preeti Kandasamy, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry (JIPMER), India</p>
</fn>
<corresp id="fn001">*Correspondence: Matthew State <email xlink:type="simple">matthew.state@ucsf.edu</email></corresp>
<corresp id="fn002">Jeremiah M. Scharf <email xlink:type="simple">jscharf@partners.org</email></corresp>
<corresp id="fn003">Peristera Paschou <email xlink:type="simple">ppaschou@mbg.duth.gr</email></corresp>
<fn fn-type="other" id="fn004">
<p>This article was submitted to Child and Adolescent Psychiatry, a section of the journal Frontiers in Neuroscience</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>03</day>
<month>8</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>10</volume>
<elocation-id>351</elocation-id>
<history>
<date date-type="received">
<day>01</day>
<month>4</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>7</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2016 Georgitsi, Willsey, Mathews, State, Scharf and Paschou.</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>Georgitsi, Willsey, Mathews, State, Scharf and Paschou</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Gilles de la Tourette Syndrome (TS) is a childhood-onset neurodevelopmental disorder that is characterized by multiple motor and phonic tics. It has a complex etiology with multiple genes likely interacting with environmental factors to lead to the onset of symptoms. The genetic basis of the disorder remains elusive. However, multiple resources and large-scale projects are coming together, launching a new era in the field and bringing us on the verge of discovery. The large-scale efforts outlined in this report are complementary and represent a range of different approaches to the study of disorders with complex inheritance. The Tourette Syndrome Association International Consortium for Genetics (TSAICG) has focused on large families, parent-proband trios and cases for large case-control designs such as genomewide association studies (GWAS), copy number variation (CNV) scans, and exome/genome sequencing. TIC Genetics targets rare, large effect size mutations in simplex trios, and multigenerational families. The European Multicentre Tics in Children Study (EMTICS) seeks to elucidate gene-environment interactions including the involvement of infection and immune mechanisms in TS etiology. Finally, TS-EUROTRAIN, a Marie Curie Initial Training Network, aims to act as a platform to unify large-scale projects in the field and to educate the next generation of experts. Importantly, these complementary large-scale efforts are joining forces to uncover the full range of genetic variation and environmental risk factors for TS, holding great promise for identifying definitive TS susceptibility genes and shedding light into the complex pathophysiology of this disorder.</p>
</abstract>
<kwd-group>
<kwd>Gilles de la Tourette syndrome</kwd>
<kwd>genetics of complex disorders</kwd>
<kwd>neurodevelopmental disorders</kwd>
<kwd>GWAS (genomewide association study)</kwd>
<kwd>gene-environment interactions</kwd>
<kwd>next generation sequencing</kwd>
<kwd>collaborative studies</kwd>
</kwd-group>
<counts>
<fig-count count="0"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="79"></ref-count>
<page-count count="9"></page-count>
<word-count count="7432"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Gilles de la Tourette Syndrome (TS; OMIM #<ext-link ext-link-type="Omim" xlink:href="137580">137580</ext-link>) is a childhood-onset neurodevelopmental disorder, characterized by motor and vocal tics. Previous prevalence estimates ranged from 0.4 to 3.8% (Robertson, <xref ref-type="bibr" rid="B62">2008</xref>); however, a recent meta-analysis refined the prevalence estimate to 0.3–0.9% (Scharf et al., <xref ref-type="bibr" rid="B64">2015</xref>). TS often presents with co-morbidities such as attention deficit hyperactivity disorder (ADHD) and obsessive-compulsive disorder (OCD) (Swain et al., <xref ref-type="bibr" rid="B70">2007</xref>), but autism spectrum disorders (ASD), depressive, and anxiety disorders may be also present (Hirschtritt et al., <xref ref-type="bibr" rid="B28">2015</xref>). This overlap across disorders supports the hypothesis of a shared neurological background and genetic susceptibility (Mathews and Grados, <xref ref-type="bibr" rid="B42">2011</xref>; Yu et al., <xref ref-type="bibr" rid="B77">2015</xref>). Twin and family studies have long established that TS bears a strong genetic component (Pauls et al., <xref ref-type="bibr" rid="B56">2014</xref>). However, TS is a complex disorder and has been associated with several environmental factors as well, with Group-A Streptococcal (GAS) infection and psychosocial stress being the most prominent among them (Hoekstra et al., <xref ref-type="bibr" rid="B29">2013</xref>; Mathews et al., <xref ref-type="bibr" rid="B43">2014</xref>). Despite the extensive research to unravel the genetic basis of TS, the field is still in its nascence. A simple PubMed search for “tic disorders” (26/3/2016) yields 5200 articles, far behind in comparison to those found for other childhood-onset neurodevelopmental disorders, such as ADHD (27,706 articles) and autism (33,167 articles), or related disorders such as OCD (16,445 articles). However, as presented at the First World Congress on Tourette Syndrome and Tic Disorders (London, June 24–26, 2015), and as described further here, the field of TS genetics stands at the precipice of discovery, thanks to the concerted efforts of multiple researchers from around the world and the coordination of multiple large-scale collaborative projects funded by the European Commission and the US National Institutes of Health.</p>
<p>The large-scale efforts outlined in this report, are complementary and represent a range of different approaches for the study of multifactorial disorders. The Tourette Syndrome Association International Consortium for Genetics (TSAICG) focuses on large families, sibpairs, trios, and cases for large case-control designs such as genomewide association studies (GWAS), copy number variation (CNV) scans, and exome/genome sequencing. TIC Genetics studies simplex trios as well as multigenerational families targeting rare, large effect size mutations. The European Multicentre Tics in Children Study (EMTICS) seeks to elucidate gene-environment interactions including the involvement of infection and immune mechanisms in TS etiology. Finally, TS-EUROTRAIN is a training network, aiming to act as a platform to unify large-scale projects in the field and educate the next generation of experts. To set the stage for the description of the aims of these consortia we briefly report the most notable findings that have shaped our current knowledge for TS genetic susceptibility (excellent exhaustive reviews are available in the literature) (State, <xref ref-type="bibr" rid="B67">2011</xref>; Deng et al., <xref ref-type="bibr" rid="B14">2012</xref>; Paschou, <xref ref-type="bibr" rid="B53">2013</xref>; Sun et al., <xref ref-type="bibr" rid="B68">2016</xref>).</p>
<sec>
<title>Candidate gene association studies</title>
<p>Based on findings from pathophysiological studies, hypotheses about the neuroanatomical regions affected in TS, and therapeutic response to neuroleptics, the first TS candidate genes were members of the dopaminergic, serotonergic, and glutamatergic pathways (Peterson et al., <xref ref-type="bibr" rid="B59">2003</xref>; Kalanithi et al., <xref ref-type="bibr" rid="B30">2005</xref>; Hartmann and Worbe, <xref ref-type="bibr" rid="B25">2013</xref>; Table <xref ref-type="table" rid="T1">1</xref>). Despite years of effort, results have been inconsistent, possibly owing to the small sample size of each individual study, the restricted number of variants explored in each study, and the inherent difficulties of candidate gene studies in genetically heterogenous disorders.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p><bold>List of genes that have so far been implicated in TS etiology</bold>.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Experimental approach by which the gene was initially identified</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Protein function</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Study sample size</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>References</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="5" rowspan="1" style="background-color:#bdbec1" valign="top">
<bold>CANDIDATE GENE</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Dopamine receptor D2</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DRD2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dopamine receptor</td>
<td align="left" colspan="1" rowspan="1" valign="top">147 TS cases/314 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Comings et al., <xref ref-type="bibr" rid="B9">1991</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">225 TS cases/67 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Comings et al., <xref ref-type="bibr" rid="B10">1996</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">151 TS cases/183 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lee et al., <xref ref-type="bibr" rid="B38">2005</xref></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">69 trios</td>
<td align="left" colspan="1" rowspan="1" valign="top">Herzberg et al., <xref ref-type="bibr" rid="B27">2010</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Dopamine receptor D4</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DRD4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dopamine receptor</td>
<td align="left" colspan="1" rowspan="1" valign="top">12 trios/3 large families</td>
<td align="left" colspan="1" rowspan="1" valign="top">Grice et al., <xref ref-type="bibr" rid="B24">1996</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">61 OCD cases with and without tics</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cruz et al., <xref ref-type="bibr" rid="B11">1997</xref></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">110 trios</td>
<td align="left" colspan="1" rowspan="1" valign="top">Díaz-Anzaldúa et al., <xref ref-type="bibr" rid="B16">2004</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Dopamine transporter [Solute carrier family 6 (neurotransmitter transporter), member 3]</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DAT1 (SLC6A3)</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dopamine transporter</td>
<td align="left" colspan="1" rowspan="1" valign="top">225 TS cases/67 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Comings et al., <xref ref-type="bibr" rid="B10">1996</xref></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">103 trios</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tarnok et al., <xref ref-type="bibr" rid="B72">2007</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">266 TS cases/236 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Yoon et al., <xref ref-type="bibr" rid="B76">2007</xref></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">110 trios</td>
<td align="left" colspan="1" rowspan="1" valign="top">Díaz-Anzaldúa et al., <xref ref-type="bibr" rid="B16">2004</xref></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">Dopamine beta hydroxylase</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DBH</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dopamine metabolism (transformation of dopamine to norepinephrine)</td>
<td align="left" colspan="1" rowspan="1" valign="top">352 TS cases/148 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Comings et al., <xref ref-type="bibr" rid="B10">1996</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Monoamine oxidase-A</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>MAOA</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dopamine and serotonin metabolism (inactivation)</td>
<td align="left" colspan="1" rowspan="1" valign="top">229 TS cases/90 relatives of TS/57 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Gade et al., <xref ref-type="bibr" rid="B22">1998</xref></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">110 trios</td>
<td align="left" colspan="1" rowspan="1" valign="top">Díaz-Anzaldúa et al., <xref ref-type="bibr" rid="B16">2004</xref></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">Serotonin receptor 1A</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HTR1A</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Serotonin receptor</td>
<td align="left" colspan="1" rowspan="1" valign="top">56 TS cases/20 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lam et al., <xref ref-type="bibr" rid="B36">1996</xref></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">Serotonin receptor 2C</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HTR2C</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Serotonin receptor</td>
<td align="left" colspan="1" rowspan="1" valign="top">87 TS cases/311 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dehning et al., <xref ref-type="bibr" rid="B13">2010</xref></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">Serotonin transporter [Solute carrier family 6 (neurotransmitter transporter), member 4]</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SERT (SLC6A4)</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Serotonin transporter</td>
<td align="left" colspan="1" rowspan="1" valign="top">151 TS cases/858 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Moya et al., <xref ref-type="bibr" rid="B47">2013</xref></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>5-HTTLPR</italic> locus</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">151 TS cases/858 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Moya et al., <xref ref-type="bibr" rid="B47">2013</xref></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">Tryptophan hydroxylase</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TPH2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Serotonin metabolism (synthesis)</td>
<td align="left" colspan="1" rowspan="1" valign="top">98 TS cases/178 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mössner et al., <xref ref-type="bibr" rid="B46">2007</xref></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">Glutamate transporter [Solute carrier family 1 (glial high affinity glutamate transporter), member 3]</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>EAAT1</italic> (<italic>SLC1A3</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glutamate transporter</td>
<td align="left" colspan="1" rowspan="1" valign="top">256 TS cases/224 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adamczyk et al., <xref ref-type="bibr" rid="B2">2011</xref></td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" style="background-color:#bdbec1" valign="top">
<bold>CHROMOSOMAL ABERRATIONS</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Slit and Trk-like, Family Member 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SLITRK1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurite outgrowth</td>
<td align="left" colspan="1" rowspan="1" valign="top">175 TS cases/2148 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Abelson et al., <xref ref-type="bibr" rid="B1">2005</xref></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">222 trios</td>
<td align="left" colspan="1" rowspan="1" valign="top">Karagiannidis et al., <xref ref-type="bibr" rid="B32">2012</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Inner mitochondrial membrane protein 2L</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>IMMP2L</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Targets proteins to the inner mitochondrial membrane (exact role unknown)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>De novo</italic> duplication in one TS patient</td>
<td align="left" colspan="1" rowspan="1" valign="top">Petek et al., <xref ref-type="bibr" rid="B58">2001</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>De novo</italic> duplication in one TS patient</td>
<td align="left" colspan="1" rowspan="1" valign="top">Kroisel et al., <xref ref-type="bibr" rid="B34">2001</xref></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>De novo</italic> translocation in one TS patient</td>
<td align="left" colspan="1" rowspan="1" valign="top">Patel et al., <xref ref-type="bibr" rid="B55">2011</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" valign="top">Contactin associated protein-like 2</td>
<td align="left" colspan="1" rowspan="2" valign="top">
<italic>CNTNAP2</italic>
</td>
<td align="left" colspan="1" rowspan="2" valign="top">Cell-cell interaction (myelinated axon-glia junction) and membrane potential (interaction with voltage-activated potassium channel)</td>
<td align="left" colspan="1" rowspan="1" valign="top">One family</td>
<td align="left" colspan="1" rowspan="1" valign="top">Verkerk et al., <xref ref-type="bibr" rid="B74">2003</xref></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">460 TS cases/1131 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fernandez et al., <xref ref-type="bibr" rid="B21">2012</xref></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">Neuroligin 4</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NLGN4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Post-synaptic cell adhesion (synaptogenesis and synapse remodeling)</td>
<td align="left" colspan="1" rowspan="1" valign="top">One family</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lawson-Yuen et al., <xref ref-type="bibr" rid="B37">2008</xref></td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" style="background-color:#bdbec1" valign="top">
<bold>COPY NUMBER VARIANTS</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Neurexin 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NRXN1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pre-synaptic cell adhesion (synapse formation)</td>
<td align="left" colspan="1" rowspan="1" valign="top">111 TS cases/73 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sundaram et al., <xref ref-type="bibr" rid="B69">2010</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">460 TS cases/1131 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fernandez et al., <xref ref-type="bibr" rid="B21">2012</xref></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">210 TS cases/285 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nag et al., <xref ref-type="bibr" rid="B49">2013</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Arylacetamide deacetylase</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>AADAC</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Detoxification (drug metabolism)—Unknown function in the brain</td>
<td align="left" colspan="1" rowspan="1" valign="top">111 TS cases/73 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sundaram et al., <xref ref-type="bibr" rid="B69">2010</xref>;</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">243 TS cases/1571 controls (initial study)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Bertelsen et al., <xref ref-type="bibr" rid="B4">2015</xref></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">1181 TS cases/118730 controls (meta-analysis)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Catenin alpha 3</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CTNNA3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cytoskeleton modeling (actin fillament assembly)</td>
<td align="left" colspan="1" rowspan="1" valign="top">111 TS cases/73 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sundaram et al., <xref ref-type="bibr" rid="B69">2010</xref></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">460 TS cases/1131 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fernandez et al., <xref ref-type="bibr" rid="B21">2012</xref></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">Fibrous sheath CABYR binding protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>FSCB</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ca2+-binding protein involved in fibrous sheath biogenesis</td>
<td align="left" colspan="1" rowspan="1" valign="top">111 TS cases/73 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sundaram et al., <xref ref-type="bibr" rid="B69">2010</xref></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">Voltage-gated potassium channel (<italic>KCNE1, KCNE2</italic>) and regulator of calcineurin 1 (<italic>RCAN1</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>KCNE1-KCNE2-RCAN1</italic> locus</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuronal cell membrane repolarization (<italic>KCNE1, KCNE2</italic>) and intracellular calcineurin-mediated signaling (<italic>RCAN1</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">111 TS cases/73 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sundaram et al., <xref ref-type="bibr" rid="B69">2010</xref></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">Collagen, type VIII, alpha 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>COL8A1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Connective tissue and basement membrane component (extracellular matrix collagen)</td>
<td align="left" colspan="1" rowspan="1" valign="top">210 TS cases/285 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nag et al., <xref ref-type="bibr" rid="B49">2013</xref></td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" style="background-color:#bdbec1" valign="top">
<bold>LINKAGE STUDIES</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Histidine decarboxylase</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HDC</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Histidine metabolism (synthesis)</td>
<td align="left" colspan="1" rowspan="1" valign="top">One large family</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ercan-Sencicek et al., <xref ref-type="bibr" rid="B20">2010</xref></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">520 trios</td>
<td align="left" colspan="1" rowspan="1" valign="top">Karagiannidis et al., <xref ref-type="bibr" rid="B31">2013</xref></td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" style="background-color:#bdbec1" valign="top">
<bold>GENOMEWIDE ASSOCIATION STUDIES</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Collagen, type XXVII, alpha 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>COL27A1</italic>
<xref ref-type="table-fn" rid="TN1">
<sup>*</sup>
</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Connective tissue component (extracellular matrix collagen)</td>
<td align="left" colspan="1" rowspan="1" valign="top">1285 TS cases/4964 controls (initial GWAS)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Scharf et al., <xref ref-type="bibr" rid="B66">2013</xref></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">1496 TS cases/5249 controls (meta-analysis)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Netrin 4</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs2060546 (proximal to <italic>NTN4</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Extracellular protein that directs axon outgrowth and guidance</td>
<td align="left" colspan="1" rowspan="1" valign="top">609 TS cases/610 controls (initial analysis)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Paschou et al., <xref ref-type="bibr" rid="B54">2014</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">1894 TS cases/5574 controls (meta-analysis)</td>
<td colspan="1" rowspan="1"></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>As described in detail in the text, associations still remain inconclusive with difficulties in replicating original positive findings. To date, the heterogeneity of the disorder and small sample sizes have been hampering the identification of TS susceptibility genes and, large scale studies like the ones described in this perspective, hold the promise to unravel the genetic basis of TS</italic>.</p>
<fn id="TN1">
<label>*</label>
<p><italic>Only the top hit is shown here. No SNP reached genomewide significance levels</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Chromosomal aberration studies</title>
<p><italic>SLITRK1</italic> has become the focus of debate in the TS literature following the discovery of a <italic>de novo</italic> inversion in a TS patient (Abelson et al., <xref ref-type="bibr" rid="B1">2005</xref>). Although follow-up studies could not find novel <italic>SLITRK1</italic> mutations in a large number of patients (Deng et al., <xref ref-type="bibr" rid="B15">2006</xref>; Chou et al., <xref ref-type="bibr" rid="B7">2007</xref>; Scharf et al., <xref ref-type="bibr" rid="B65">2008</xref>; Zimprich et al., <xref ref-type="bibr" rid="B79">2008</xref>; Miranda et al., <xref ref-type="bibr" rid="B45">2009</xref>), tagging-SNP-based association studies supported the implication of unidentified <italic>SLITRK1</italic> regulatory variants (Miranda et al., <xref ref-type="bibr" rid="B45">2009</xref>; Karagiannidis et al., <xref ref-type="bibr" rid="B32">2012</xref>). Tracing chromosomal aberrations in TS patients, <italic>IMMP2L</italic> has also been implicated in TS (Boghosian-Sell et al., <xref ref-type="bibr" rid="B5">1996</xref>; Kroisel et al., <xref ref-type="bibr" rid="B34">2001</xref>; Petek et al., <xref ref-type="bibr" rid="B58">2001</xref>; Patel et al., <xref ref-type="bibr" rid="B55">2011</xref>; Katuwawela, <xref ref-type="bibr" rid="B33">2012</xref>) and other neurodevelopmental disorders, such as ASD, ADHD and dyslexia (Elia et al., <xref ref-type="bibr" rid="B19">2010</xref>; Maestrini et al., <xref ref-type="bibr" rid="B40">2010</xref>; Pagnamenta et al., <xref ref-type="bibr" rid="B51">2010</xref>; Girirajan et al., <xref ref-type="bibr" rid="B23">2011</xref>); yet <italic>IMMP2L</italic> coding mutations have not been identified (Petek et al., <xref ref-type="bibr" rid="B57">2007</xref>). Other cytogenetic abnormalities associated with TS have implicated signal transduction and cell-adhesion proteins, such as CNTNAP2 (Verkerk et al., <xref ref-type="bibr" rid="B74">2003</xref>; Poot et al., <xref ref-type="bibr" rid="B60">2010</xref>) and NLGN4 (Lawson-Yuen et al., <xref ref-type="bibr" rid="B37">2008</xref>; Table <xref ref-type="table" rid="T1">1</xref>).</p>
</sec>
<sec>
<title>CNV studies</title>
<p>Scans of structural variations in relation to TS have revealed <italic>de novo</italic> or recurrent rare CNVs in multiple genes (Table <xref ref-type="table" rid="T1">1</xref>). Of particular interest is the significant overlap of rare CNVs observed in TS individuals with patients of other neuropsychiatric and neurodevelopmental disorders, including OCD, autism, ASD, and schizophrenia, suggesting shared etiology (Sundaram et al., <xref ref-type="bibr" rid="B69">2010</xref>; Fernandez et al., <xref ref-type="bibr" rid="B21">2012</xref>; McGrath et al., <xref ref-type="bibr" rid="B44">2014</xref>).</p>
</sec>
<sec>
<title>Linkage analysis studies</title>
<p>Early linkage studies on large multigenerational pedigrees failed to identify a major TS susceptibility gene (Deng et al., <xref ref-type="bibr" rid="B14">2012</xref>; Paschou, <xref ref-type="bibr" rid="B53">2013</xref>), and the single-gene hypothesis was soon abandoned. Recently, Ercan-Sencicek et al. identified an extremely rare non-sense mutation in <italic>HDC</italic>, in a unique family with several affected siblings, spurring again the interest for monogenic TS and introducing the involvement of the, until recently, ignored histaminergic pathway and its role in striatal dopamine regulation (Ercan-Sencicek et al., <xref ref-type="bibr" rid="B20">2010</xref>; Castellan Baldan et al., <xref ref-type="bibr" rid="B6">2014</xref>; Rapanelli et al., <xref ref-type="bibr" rid="B61">2014</xref>). Although <italic>HDC</italic> mutations have been extremely rare in the literature (Lei et al., <xref ref-type="bibr" rid="B39">2012</xref>), there is still evidence for association of the histaminergic pathway genes and TS (Fernandez et al., <xref ref-type="bibr" rid="B21">2012</xref>; Karagiannidis et al., <xref ref-type="bibr" rid="B31">2013</xref>).</p>
</sec>
<sec>
<title>GWAS studies</title>
<p>The first TS GWAS was published in 2013, including 1285 cases and 4964 ancestry-matched controls. While no marker achieved a genomewide significance threshold, the strongest signal was observed for an intronic single nucleotide polymorphism (SNP) in <italic>COL27A1</italic> (Scharf et al., <xref ref-type="bibr" rid="B66">2013</xref>). Moreover, a replication study of 42 top-signal SNPs from the first TS GWAS in 609 independent cases and 610 ancestry-matched controls, revealed the most significant association to date with a SNP lying closest to <italic>NTN4</italic>, an axon guidance molecule expressed in the developing striatum (Paschou et al., <xref ref-type="bibr" rid="B54">2014</xref>). The first ever epigenome-wide association study of tic disorders revealed association signals nearby genes previously associated with neurological disorders that warrant further investigation (Zilhão et al., <xref ref-type="bibr" rid="B78">2015</xref>).</p>
</sec>
</sec>
<sec id="s2">
<title>The tourette syndrome association international consortium for genetics (TSAICG)—genomewide association studies for TS</title>
<p>The TSAICG was founded in 1986 by TS genetic researchers in the United States and The Netherlands and brought together by the TSA-USA to exchange ideas and share preliminary data with the goal of identifying TS susceptibility genes. Early studies focused on parametric linkage analyses in large, multi-generational TS families (Pakstis et al., <xref ref-type="bibr" rid="B52">1991</xref>; Barr et al., <xref ref-type="bibr" rid="B3">1999</xref>) under the assumption that TS was a monogenic disorder. However, as evidence mounted to indicate the presence of non-Mendelian inheritance (Kurlan et al., <xref ref-type="bibr" rid="B35">1994</xref>; Hasstedt et al., <xref ref-type="bibr" rid="B26">1995</xref>), the TSAICG expanded to 11 clinical sites in USA, Canada, Germany, the UK, and the Netherlands to collect TS affected sibling pairs for non-parametric analyses using a standardized phenotypic assessment for TS, OCD, and ADHD, still used today by the three international TS consortia discussed here. The TSAICG was awarded NIH funding in 2000 to collect additional small nuclear families and completed a high-density linkage study of all existing affected sibpairs and multi-generational families (TSAICG, <xref ref-type="bibr" rid="B73">2007</xref>). These analyses of over 2000 individuals identified a genomewide significant non-parametric linkage signal on chromosome 2p (TSAICG, <xref ref-type="bibr" rid="B73">2007</xref>), though subsequent analyses have demonstrated significant heterogeneity across this locus, consistent with the presence of multiple distinct signals within the linkage region (O'Rourke et al., <xref ref-type="bibr" rid="B50">2009</xref>). With the advent of the GWAS era, the TSAICG changed its collection goals to focus on association studies using both parent-proband trios and individual TS cases. These collections served as the basis for the first TS GWAS and parallel CNV analysis as described above (Scharf et al., <xref ref-type="bibr" rid="B66">2013</xref>; McGrath et al., <xref ref-type="bibr" rid="B44">2014</xref>). As it became clear that sample size is the major hindrance to gene discovery for complex neuropsychiatric traits, the TSAICG added additional recruitment sites and novel recruitment and assessment methods, such as web-based assessments of previously diagnosed TS cases and remote DNA collection using commercial laboratories across the US (Egan et al., <xref ref-type="bibr" rid="B18">2012</xref>; Darrow et al., <xref ref-type="bibr" rid="B12">2015</xref>). These online protocols facilitated collection of 1600 independent TS cases over the course of 2 years, a sample that served as the basis for the second TS GWAS and CNV studies whose preliminary results were presented at the First World Congress on Tourette Syndrome and Tic Disorders (to be published by fall 2016).</p>
<p>Each of these large-scale TS genetic studies have relied heavily on extended collaborations and data sharing, both within the TSAICG as well as across additional US and European research groups. The Gilles de la Tourette Syndrome GWAS Replication Initiative (GGRI) consists of multiple TS research groups across USA, Canada, France, Germany, Austria, Hungary, Italy, Greece and Poland, and formed out of an NIH TS Genetics Workshop following completion of the first TS GWAS. The GGRI collaborative resulted in both the targeted replication study described above (Paschou et al., <xref ref-type="bibr" rid="B54">2014</xref>) and acted as another major contributing source for the second international TS GWAS and CNV studies. Similarly, TIC Genetics has contributed data from over 400 TS parent-proband trios to the latest TS GWAS. TSAICG and TIC Genetics are also currently collaborating in a joint analysis of exome sequencing data aimed at identifying recurrent, <italic>de novo</italic> mutations in TS parent-proband trio families (see below). Most recently, all of the above collaborative groups have also contributed their GWAS data to the Psychiatric Genomics Consortium (PGC) and formed the TS component of the TS and OCD Working Group of the PGC.</p>
</sec>
<sec id="s3">
<title>The tourette international collaborative genetics (TIC genetics) study—whole exome sequencing in families with TS</title>
<p>The TIC Genetics Study is a large, multi-center effort established in 2011 (<ext-link ext-link-type="uri" xlink:href="http://tic-genetics.org">http://tic-genetics.org</ext-link>) with several goals, including (1) to create a large, central repository for sharing clinical data and biomaterials from genotypically and phenotypically well-characterized affected individuals and their relatives; (2) to increase our understanding of the genetic architecture of tic disorders through identification of risk genes and loci, and enumeration of the number of these genes and loci that contribute risk; and (3) to leverage these findings alongside systems biological approaches to provide insights into the neurobiology underlying these disorders (Dietrich et al., <xref ref-type="bibr" rid="B17">2014</xref>).</p>
<p>Patients are recruited at more than 20 sites from USA, Europe, and South Korea, including academic research and mental health care centers (Dietrich et al., <xref ref-type="bibr" rid="B17">2014</xref>). Recruiting focusses on both multiplex families and apparently-simplex trios. Following extensive phenotyping, blood is drawn and processed at the NIMH Center for Collaborative Genomics Research on Mental Disorders at RUCDR (<ext-link ext-link-type="uri" xlink:href="http://www.rucdr.org">http://www.rucdr.org</ext-link>) for DNA and RNA extraction, lymphocytes cryopreservation, and lymphoblastoid cell lines establishment. Anonymized clinical data and biomaterials are stored in a sharing repository located within the National Institute for Mental Health Center for Collaborative Genomics Research on Mental Disorders (<ext-link ext-link-type="uri" xlink:href="http://www.nimhgenetics.org">www.nimhgenetics.org</ext-link>). Importantly, this study has been designed to optimize compatibility with other TS genetic consortia and researchers, as this will be critical to advancing our understanding of this disorder (Dietrich et al., <xref ref-type="bibr" rid="B17">2014</xref>).</p>
<p>The TIC Genetics study leverages multiple genomewide approaches for identifying rare, large effect size variants, focusing both on identifying highly penetrant genetic variants segregating in multiply affected pedigrees and on <italic>de novo</italic> mutations identified in simplex families. Genomewide methods include genotyping microarrays for linkage analysis (Ercan-Sencicek et al., <xref ref-type="bibr" rid="B20">2010</xref>) and CNV detection (Fernandez et al., <xref ref-type="bibr" rid="B21">2012</xref>), and whole-exome sequencing (WES) for SNP and insertion-deletion variant (indel) detection. Efforts of TIC Genetics investigators led to the implication of histaminergic pathway genes in TS etiology (Ercan-Sencicek et al., <xref ref-type="bibr" rid="B20">2010</xref>; Fernandez et al., <xref ref-type="bibr" rid="B21">2012</xref>).</p>
<p>TIC Genetics is currently finishing analysis of WES data from 325 simplex TS trios. The main focus is the detection of <italic>de novo</italic> SNPs and indels, largely due to the success of this gene discovery approach in ASD (Sanders et al., <xref ref-type="bibr" rid="B63">2015</xref>). Because of the rarity of <italic>de novo</italic> mutations and their large effect size, recurrent mutations can be leveraged to identify risk genes with high confidence. Excitingly, the identification of risk genes, in a hypothesis-free manner, facilitates systems biological analyses aimed at answering critical questions about the underlying neurobiology of TS. Systems approaches alongside gene-expression data from the developing human brain may have already been quite fruitful in this regard (Willsey et al., <xref ref-type="bibr" rid="B75">2013</xref>).</p>
</sec>
<sec id="s4">
<title>EMTICS: european multicentre tics in children study; exploring gene-environment interactions that underlie TS etiology</title>
<p>EMTICS is a multi-national study funded by the European Commission under the Seventh Framework Programme, including 17 clinical sites from across Europe (<ext-link ext-link-type="uri" xlink:href="http://emtics.eu">http://emtics.eu</ext-link>). It is prospectively designed to offer, for the first time, the opportunity to evaluate environmental risk factors that may lead to tic exacerbation but also, new tic onset, while correlating to genomic background. Two unique patient cohorts form the core of EMTICS: The ONSET study involves follow-up of 375 high-risk children aged 3–10 years who have a first degree relative with a diagnosis of TS and at study entry have no tics. The COURSE study includes and follows for up to 3 years, 700 children, and adolescents aged 3–16 years with a known chronic tic disorder or TS.</p>
<p>Individual genetic background alone cannot predict the risk for TS and a role of exposure to psychosocial stress, pre- and perinatal difficulties, and GAS infections (Hoekstra et al., <xref ref-type="bibr" rid="B29">2013</xref>; Mathews et al., <xref ref-type="bibr" rid="B43">2014</xref>) in TS etiology has been shown. The human pathogen GAS is a major cause of common pharyngitis, but also of significant post-streptococcal autoimmune multi-organ sequelae associated with the existence of host autoantibodies against GAS antigens, including rheumatic fever and Sydenham's chorea (Church et al., <xref ref-type="bibr" rid="B8">2002</xref>). In the 1990s, Swedo et al. (<xref ref-type="bibr" rid="B71">1998</xref>) described a clinical phenotype, named Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS). Although it is still controversial whether PANDAS criteria can be used to designate a unique clinical entity, further research into the potential role of the innate and adaptive immune systems in the pathogenesis of tics and OCD is warranted (Martino et al., <xref ref-type="bibr" rid="B41">2009</xref>; Murphy et al., <xref ref-type="bibr" rid="B48">2010</xref>). The etiological link between GAS infections and TS/OCD may be related to an autoimmune process, following the model of molecular mimicry, according to which structural similarity between streptococcal and cerebral antigens might elicit a pathogenic cross-reactivity of antibodies originally targeting GAS antigens to host antigens.</p>
<p>Within EMTICS, the main hypothesis is that the onset of TS is dependent on identifiable genetic factors interacting with identifiable environmental factors. The study aims to test the likelihood that the development of new tics or tic exacerbation in individuals with a specific genetic background, is increased by recent exposure to pharyngeal GAS carriage or infection. The study investigates the genomic background of studied individuals through genomewide genotyping, in relation to new tic onset and tic exacerbation, correlating to the presence of GAS in throat swabs, comorbidities, pre- and perinatal difficulties, psychosocial stress (also measured via cortisol levels in hair follicles), and immunological measures. Transcriptome-wide gene-expression profiles of patients at points of tic exacerbation and tic remission as well as before and after tic onset in newly-diagnosed patients will also reveal, for the first time, pathways that are activated during the course or onset of TS. The first patient was enrolled in March 2013 and the study will conclude in 2017. The potential observation of a pathogenic link between an environmental immune-activating factor and risk for the development of a tic disorder and/or OCD may pave the way to the application of immune-modulating prophylactic and treatment approaches in these conditions.</p>
</sec>
<sec id="s5">
<title>TS-EUROTRAIN—coordinating large-scale studies and training the next generation of experts for TS</title>
<p>In an effort to address the need for large-scale collaboration in order to tackle the multi-faceted etiology of TS but also train the next generation of young experts in the field, the Marie Curie Initial Training Network TS-EUROTRAIN was established, supported by the European Commission (<ext-link ext-link-type="uri" xlink:href="http://ts-eurotrain.eu">http://ts-eurotrain.eu</ext-link>). Collaborative efforts of 14 academic institutes along with 12 PhD students form a highly multidisciplinary and inter-sectorial team, with the European experts in the study of TS collaborating with leading scientists in the USA. Building bridges between academia and industry is key to the network with two industrial partners providing pioneering expertise to the network: deCODE Genetics, a large genetic services and research provider and Boehringer Ingelheim PHARMA, one of the 20 largest pharmaceutical companies in the world. Twelve individual, yet complementary, projects interact to form a comprehensive study of TS and comorbidities from genetics and epigenetics through to physiology, brain anatomy, and function. These projects can roughly be divided into three groups by their main approach; genetic (and epigenetic), animal models, and human neuroimaging, respectively.</p>
<p>TS-EUROTRAIN aspires to act as an interface bringing together multiple large-scale efforts in the field. The main scientific goals are to assemble and interrogate a large genetic database for the evaluation of the genetic architecture of TS, to explore the role of gene-environment interactions in TS etiology including, for the first time, the effects of epigenetic phenomena, and to gain new insights into the neurobiological mechanisms of TS via cross-sectional and longitudinal neuroimaging studies and animal studies. Among the main expected outcomes of TS-EUROTRAIN will be the largest meta-analysis of European patient cohorts, resulting in a total of about 3000 patients with TS analysed for about 700,000 genetic markers across the genome as well as genomewide CNV studies in European patient cohorts. Furthermore, already, TS-EUROTRAIN has produced the first ever epigenome-wide association study for tics, analysing data from the Netherlands Twin Register (Zilhão et al., <xref ref-type="bibr" rid="B78">2015</xref>). This study interrogated 411,469 autosomal methylation sites in 1678 individuals. Although no site reached genomewide significance, the top hits include several genes and regions previously associated with neurological disorders and warrant further investigation (Zilhão et al., <xref ref-type="bibr" rid="B78">2015</xref>). Systems biology approaches and integration of data from multiple sources are main aspects of TS-EUROTRAIN methodology. Thus, large-scale data analysis and novel algorithm development for integration of data from “omics” platforms but also clinical and neuroimaging data are important parts of the study.</p>
<p>The academic and industrial partners form a unified training infrastructure to provide interdisciplinary training for TS. Specialized training covers cutting-edge scientific areas ranging from basic neuroscience and genomics to bioinformatics and computer science. Direct interaction of the network with European patient groups (Tourette-Gesellschaft Deutschland e.V., Germany and Netherlands Foundation of patients with TS, Netherlands) provides a unique opportunity to learn from patients and disseminate scientific knowledge of TS to large non-scientific audiences. Undertaking a comprehensive scientific and outreach programme, TS-EUROTRAIN aims to build Pan-European infrastructure and render TS into an example disorder for the study of other neurodevelopmental disorders and the development of European policies for the promotion of childhood mental health.</p>
</sec>
<sec id="s6" sec-type="conclusions">
<title>Conclusions</title>
<p>Collaborative efforts of dedicated researchers from around the world have brought us on the verge of a new era, promising exciting, and rapid discoveries in the field of TS genetics. Multiple resources are coming together for TS genetic research; large well-characterized patient cohorts, specialized epidemiological databases, novel genomics technologies, and sophisticated methodology for the analysis of large-scale datasets. Systems biology approaches and integration of data from multiple sources and “omics” platforms can be expected to reveal novel facets of TS etiology, while cross-disorder meta-analysis for the identification of overlapping risk factors is shifting our view toward a whole spectrum of neurodevelopmental phenotypes. Importantly, the individual large-scale efforts described here, are ultimately joining their powers with the goal to boost power and identify definitive susceptibility genes for TS. These scientific alliances in concert with parallel large scale efforts in psychiatric genetics such as the PGC hold the promise to get us over the “precipice” and enter a new phase in TS gene discovery that may lead us to new pathophysiologic mechanisms underlying the disorder.</p>
</sec>
<sec id="s7">
<title>Author contributions</title>
<p>All authors listed, have made substantial, direct and intellectual contribution to the work, and approved it for publication.</p>
</sec>
<sec>
<title>Funding</title>
<p>EMTICS and TS-EUROTRAIN are funded by the European Union under the Seventh Framework People Programme (TS-EUROTRAIN (FP7-PEOPLE-2012-ITN), Grant Agr.No.316978—EMTICS (FP7/2007-2013), Grant Agr.No. 278367). TSAICG is funded by NIH U01NS40024, U01NS40024-09S1, K23MH085057, R01MH096767, K02NS085048, and research funding from the Tourette Association of America. TIC Genetics is funded by NIH (R01MH092290; R01MH092291; R01MH092292; R01MH092293; R01MH092513; R01MH092516; R01MH092520; R01MH092289; U24MH068457) and the New Jersey Center for Tourette Syndrome and Associated Disorders (NJCTS).</p>
<sec>
<title>Conflict of interest statement</title>
<p>JS and CM have received grant and travel support from the Tourette Association of America. The other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ack>
<p>We would like to thank all the patients and families who participated in these studies in the hope of increasing knowledge about the causes of TS and identifying new treatments. This article was motivated by the First World Congress on Tourette Syndrome and Tic Disorders and is supported by the Tourette Association of America. Research reported in this publication was supported by a Conference Grant from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number R13NS095344. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abelson</surname><given-names>J. F.</given-names></name><name><surname>Kwan</surname><given-names>K. Y.</given-names></name><name><surname>O'Roak</surname><given-names>B. J.</given-names></name><name><surname>Baek</surname><given-names>D. Y.</given-names></name><name><surname>Stillman</surname><given-names>A. A.</given-names></name><name><surname>Morgan</surname><given-names>T. M.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Sequence variants in SLITRK1 are associated with Tourette's syndrome</article-title>. <source/>Science
<volume>310</volume>, <fpage>317</fpage>–<lpage>320</lpage>. <pub-id pub-id-type="doi">10.1126/science.1116502</pub-id><pub-id pub-id-type="pmid">16224024</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adamczyk</surname><given-names>A.</given-names></name><name><surname>Gause</surname><given-names>C. D.</given-names></name><name><surname>Sattler</surname><given-names>R.</given-names></name><name><surname>Vidensky</surname><given-names>S.</given-names></name><name><surname>Rothstein</surname><given-names>J. D.</given-names></name><name><surname>Singer</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Genetic and functional studies of a missense variant in a glutamate transporter, SLC1A3, in Tourette syndrome</article-title>. <source/>Psychiatr. Genet.
<volume>21</volume>, <fpage>90</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1097/YPG.0b013e328341a307</pub-id><pub-id pub-id-type="pmid">21233784</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barr</surname><given-names>C. L.</given-names></name><name><surname>Wigg</surname><given-names>K. G.</given-names></name><name><surname>Pakstis</surname><given-names>A. J.</given-names></name><name><surname>Kurlan</surname><given-names>R.</given-names></name><name><surname>Pauls</surname><given-names>D.</given-names></name><name><surname>Kidd</surname><given-names>K. K.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>Genome scan for linkage to Gilles de la Tourette syndrome</article-title>. <source/>Am. J. Med. Genet.
<volume>88</volume>, <fpage>437</fpage>–<lpage>445</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(19990820)88:4&lt;437::AID-AJMG24&gt;3.0.CO;2-E</pub-id><pub-id pub-id-type="pmid">10402514</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertelsen</surname><given-names>B.</given-names></name><name><surname>Melchior</surname><given-names>L.</given-names></name><name><surname>Jensen</surname><given-names>L. R.</given-names></name><name><surname>Groth</surname><given-names>C.</given-names></name><name><surname>Nazaryan</surname><given-names>L.</given-names></name><name><surname>Debes</surname><given-names>N. M.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>A t(3;9)(q25.1;q34.3) translocation leading to OLFM1 fusion transcripts in Gilles de la Tourette syndrome, OCD and ADHD</article-title>. <source/>Psychiatry Res.
<volume>225</volume>, <fpage>268</fpage>–<lpage>275</lpage>. <pub-id pub-id-type="doi">10.1016/j.psychres.2014.12.028</pub-id><pub-id pub-id-type="pmid">25595337</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boghosian-Sell</surname><given-names>L.</given-names></name><name><surname>Comings</surname><given-names>D. E.</given-names></name><name><surname>Overhauser</surname><given-names>J.</given-names></name></person-group> (<year>1996</year>). <article-title>Tourette syndrome in a pedigree with a 7;18 translocation: identification of a YAC spanning the translocation breakpoint at 18q22.3</article-title>. <source/>Am. J. Hum. Genet.
<volume>59</volume>, <fpage>999</fpage>–<lpage>1005</lpage>. <pub-id pub-id-type="pmid">8900226</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castellan Baldan</surname><given-names>L.</given-names></name><name><surname>Williams</surname><given-names>K. A.</given-names></name><name><surname>Gallezot</surname><given-names>J.-D.</given-names></name><name><surname>Pogorelov</surname><given-names>V.</given-names></name><name><surname>Rapanelli</surname><given-names>M.</given-names></name><name><surname>Crowley</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice</article-title>. <source/>Neuron
<volume>81</volume>, <fpage>77</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2013.10.052</pub-id><pub-id pub-id-type="pmid">24411733</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chou</surname><given-names>I.-C.</given-names></name><name><surname>Wan</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>S.-C.</given-names></name><name><surname>Tsai</surname><given-names>C.-H.</given-names></name><name><surname>Tsai</surname><given-names>F.-J.</given-names></name></person-group> (<year>2007</year>). <article-title>Association of the Slit and Trk-like 1 gene in Taiwanese patients with Tourette syndrome</article-title>. <source/>Pediatr. Neurol.
<volume>37</volume>, <fpage>404</fpage>–<lpage>406</lpage>. <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2007.06.017</pub-id><pub-id pub-id-type="pmid">18021920</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Church</surname><given-names>A. J.</given-names></name><name><surname>Cardoso</surname><given-names>F.</given-names></name><name><surname>Dale</surname><given-names>R. C.</given-names></name><name><surname>Lees</surname><given-names>A. J.</given-names></name><name><surname>Thompson</surname><given-names>E. J.</given-names></name><name><surname>Giovannoni</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea</article-title>. <source/>Neurology
<volume>59</volume>, <fpage>227</fpage>–<lpage>231</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.59.2.227</pub-id><pub-id pub-id-type="pmid">12136062</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Comings</surname><given-names>D. E.</given-names></name><name><surname>Comings</surname><given-names>B. G.</given-names></name><name><surname>Muhleman</surname><given-names>D.</given-names></name><name><surname>Dietz</surname><given-names>G.</given-names></name><name><surname>Shahbahrami</surname><given-names>B.</given-names></name><name><surname>Tast</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>1991</year>). <article-title>The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders</article-title>. <source/>JAMA
<volume>266</volume>, <fpage>1793</fpage>–<lpage>1800</lpage>. <pub-id pub-id-type="doi">10.1001/jama.1991.03470130073032</pub-id><pub-id pub-id-type="pmid">1832466</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Comings</surname><given-names>D. E.</given-names></name><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Chiu</surname><given-names>C.</given-names></name><name><surname>Ring</surname><given-names>R. H.</given-names></name><name><surname>Gade</surname><given-names>R.</given-names></name><name><surname>Ahn</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>1996</year>). <article-title>Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes–DRD2, D beta H, and DAT1</article-title>. <source/>Am. J. Med. Genet.
<volume>67</volume>, <fpage>264</fpage>–<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(19960531)67:3&lt;264::AID-AJMG4&gt;3.0.CO;2-N</pub-id><pub-id pub-id-type="pmid">8725745</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruz</surname><given-names>C.</given-names></name><name><surname>Camarena</surname><given-names>B.</given-names></name><name><surname>King</surname><given-names>N.</given-names></name><name><surname>Páez</surname><given-names>F.</given-names></name><name><surname>Sidenberg</surname><given-names>D.</given-names></name><name><surname>de la Fuente</surname><given-names>J. R.</given-names></name><etal></etal></person-group>. (<year>1997</year>). <article-title>Increased prevalence of the seven-repeat variant of the dopamine D4 receptor gene in patients with obsessive-compulsive disorder with tics</article-title>. <source/>Neurosci. Lett.
<volume>231</volume>, <fpage>1</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="pmid">9280153</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darrow</surname><given-names>S. M.</given-names></name><name><surname>Illmann</surname><given-names>C.</given-names></name><name><surname>Gauvin</surname><given-names>C.</given-names></name><name><surname>Osiecki</surname><given-names>L.</given-names></name><name><surname>Egan</surname><given-names>C. A.</given-names></name><name><surname>Greenberg</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Web-based phenotyping for Tourette Syndrome: reliability of common co-morbid diagnoses</article-title>. <source/>Psychiatry Res.
<volume>228</volume>, <fpage>816</fpage>–<lpage>825</lpage>. <pub-id pub-id-type="doi">10.1016/j.psychres.2015.05.017</pub-id><pub-id pub-id-type="pmid">26054936</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dehning</surname><given-names>S.</given-names></name><name><surname>Müller</surname><given-names>N.</given-names></name><name><surname>Matz</surname><given-names>J.</given-names></name><name><surname>Bender</surname><given-names>A.</given-names></name><name><surname>Kerle</surname><given-names>I.</given-names></name><name><surname>Benninghoff</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>A genetic variant of HTR2C may play a role in the manifestation of Tourette syndrome</article-title>. <source/>Psychiatr. Genet.
<volume>20</volume>, <fpage>35</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1097/YPG.0b013e32833511ce</pub-id><pub-id pub-id-type="pmid">20010450</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>H.</given-names></name><name><surname>Gao</surname><given-names>K.</given-names></name><name><surname>Jankovic</surname><given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>The genetics of Tourette syndrome</article-title>. <source/>Nat. Rev. Neurol.
<volume>8</volume>, <fpage>203</fpage>–<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2012.26</pub-id><pub-id pub-id-type="pmid">22410579</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>H.</given-names></name><name><surname>Le</surname><given-names>W. D.</given-names></name><name><surname>Xie</surname><given-names>W. J.</given-names></name><name><surname>Jankovic</surname><given-names>J.</given-names></name></person-group> (<year>2006</year>). <article-title>Examination of the SLITRK1 gene in Caucasian patients with Tourette syndrome</article-title>. <source/>Acta Neurol. Scand.
<volume>114</volume>, <fpage>400</fpage>–<lpage>402</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0404.2006.00706.x</pub-id><pub-id pub-id-type="pmid">17083340</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Díaz-Anzaldúa</surname><given-names>A.</given-names></name><name><surname>Joober</surname><given-names>R.</given-names></name><name><surname>Rivière</surname><given-names>J.-B.</given-names></name><name><surname>Dion</surname><given-names>Y.</given-names></name><name><surname>Lespérance</surname><given-names>P.</given-names></name><name><surname>Richer</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Tourette syndrome and dopaminergic genes: a family-based association study in the French Canadian founder population</article-title>. <source/>Mol. Psychiatry
<volume>9</volume>, <fpage>272</fpage>–<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4001411</pub-id><pub-id pub-id-type="pmid">15094788</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dietrich</surname><given-names>A.</given-names></name><name><surname>Fernandez</surname><given-names>T. V.</given-names></name><name><surname>King</surname><given-names>R. A.</given-names></name><name><surname>State</surname><given-names>M. W.</given-names></name><name><surname>Tischfield</surname><given-names>J. A.</given-names></name><name><surname>Hoekstra</surname><given-names>P. J.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>The Tourette International Collaborative Genetics (TIC Genetics) study, finding the genes causing Tourette syndrome: objectives and methods</article-title>. <source/>Eur. Child Adolesc. Psychiatry
<volume>24</volume>, <fpage>141</fpage>–<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1007/s00787-014-0543-x</pub-id><pub-id pub-id-type="pmid">24771252</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egan</surname><given-names>C. A.</given-names></name><name><surname>Marakovitz</surname><given-names>S. E.</given-names></name><name><surname>O'Rourke</surname><given-names>J. A.</given-names></name><name><surname>Osiecki</surname><given-names>L.</given-names></name><name><surname>Illmann</surname><given-names>C.</given-names></name><name><surname>Barton</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Effectiveness of a web-based protocol for the screening and phenotyping of individuals with Tourette syndrome for genetic studies</article-title>. <source/>Am. J. Med. Genet. B Neuropsychiatr. Genet.
<volume>159B</volume>, <fpage>987</fpage>–<lpage>996</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.32107</pub-id><pub-id pub-id-type="pmid">23090870</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elia</surname><given-names>J.</given-names></name><name><surname>Gai</surname><given-names>X.</given-names></name><name><surname>Xie</surname><given-names>H. M.</given-names></name><name><surname>Perin</surname><given-names>J. C.</given-names></name><name><surname>Geiger</surname><given-names>E.</given-names></name><name><surname>Glessner</surname><given-names>J. T.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes</article-title>. <source/>Mol. Psychiatry
<volume>15</volume>, <fpage>637</fpage>–<lpage>646</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2009.57</pub-id><pub-id pub-id-type="pmid">19546859</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ercan-Sencicek</surname><given-names>A. G.</given-names></name><name><surname>Stillman</surname><given-names>A. A.</given-names></name><name><surname>Ghosh</surname><given-names>A. K.</given-names></name><name><surname>Bilguvar</surname><given-names>K.</given-names></name><name><surname>O'Roak</surname><given-names>B. J.</given-names></name><name><surname>Mason</surname><given-names>C. E.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>L-histidine decarboxylase and Tourette's syndrome</article-title>. <source/>N. Engl. J. Med.
<volume>362</volume>, <fpage>1901</fpage>–<lpage>1908</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa0907006</pub-id><pub-id pub-id-type="pmid">20445167</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez</surname><given-names>T. V.</given-names></name><name><surname>Sanders</surname><given-names>S. J.</given-names></name><name><surname>Yurkiewicz</surname><given-names>I. R.</given-names></name><name><surname>Ercan-Sencicek</surname><given-names>A. G.</given-names></name><name><surname>Kim</surname><given-names>Y.-S. S.</given-names></name><name><surname>Fishman</surname><given-names>D. O.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Rare copy number variants in tourette syndrome disrupt genes in histaminergic pathways and overlap with autism</article-title>. <source/>Biol. Psychiatry
<volume>71</volume>, <fpage>392</fpage>–<lpage>402</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2011.09.034</pub-id><pub-id pub-id-type="pmid">22169095</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gade</surname><given-names>R.</given-names></name><name><surname>Muhleman</surname><given-names>D.</given-names></name><name><surname>Blake</surname><given-names>H.</given-names></name><name><surname>MacMurray</surname><given-names>J.</given-names></name><name><surname>Johnson</surname><given-names>P.</given-names></name><name><surname>Verde</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>1998</year>). <article-title>Correlation of length of VNTR alleles at the X-linked MAOA gene and phenotypic effect in Tourette syndrome and drug abuse</article-title>. <source/>Mol. Psychiatry
<volume>3</volume>, <fpage>50</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="pmid">9491813</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girirajan</surname><given-names>S.</given-names></name><name><surname>Brkanac</surname><given-names>Z.</given-names></name><name><surname>Coe</surname><given-names>B. P.</given-names></name><name><surname>Baker</surname><given-names>C.</given-names></name><name><surname>Vives</surname><given-names>L.</given-names></name><name><surname>Vu</surname><given-names>T. H.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Relative burden of large CNVs on a range of neurodevelopmental phenotypes</article-title>. <source/>PLoS Genet.
<volume>7</volume>:<fpage>e1002334</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1002334</pub-id><pub-id pub-id-type="pmid">22102821</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grice</surname><given-names>D. E.</given-names></name><name><surname>Leckman</surname><given-names>J. F.</given-names></name><name><surname>Pauls</surname><given-names>D. L.</given-names></name><name><surname>Kurlan</surname><given-names>R.</given-names></name><name><surname>Kidd</surname><given-names>K. K.</given-names></name><name><surname>Pakstis</surname><given-names>A. J.</given-names></name><etal></etal></person-group>. (<year>1996</year>). <article-title>Linkage disequilibrium between an allele at the dopamine D4 receptor locus and Tourette syndrome, by the transmission-disequilibrium test</article-title>. <source/>Am. J. Hum. Genet.
<volume>59</volume>, <fpage>644</fpage>–<lpage>652</lpage>. <pub-id pub-id-type="pmid">8751866</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartmann</surname><given-names>A.</given-names></name><name><surname>Worbe</surname><given-names>Y.</given-names></name></person-group> (<year>2013</year>). <article-title>Pharmacological treatment of Gilles de la Tourette syndrome</article-title>. <source/>Neurosci. Biobehav. Rev.
<volume>37</volume>, <fpage>1157</fpage>–<lpage>1161</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2012.10.014</pub-id><pub-id pub-id-type="pmid">23137552</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasstedt</surname><given-names>S. J.</given-names></name><name><surname>Leppert</surname><given-names>M.</given-names></name><name><surname>Filloux</surname><given-names>F.</given-names></name><name><surname>van de Wetering</surname><given-names>B. J.</given-names></name><name><surname>McMahon</surname><given-names>W. M.</given-names></name></person-group> (<year>1995</year>). <article-title>Intermediate inheritance of Tourette syndrome, assuming assortative mating</article-title>. <source/>Am. J. Hum. Genet.
<volume>57</volume>, <fpage>682</fpage>–<lpage>689</lpage>. <pub-id pub-id-type="pmid">7668298</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herzberg</surname><given-names>I.</given-names></name><name><surname>Valencia-Duarte</surname><given-names>A. V.</given-names></name><name><surname>Kay</surname><given-names>V. A.</given-names></name><name><surname>White</surname><given-names>D. J.</given-names></name><name><surname>Müller</surname><given-names>H.</given-names></name><name><surname>Rivas</surname><given-names>I. C.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Association of DRD2 variants and Gilles de la Tourette syndrome in a family-based sample from a South American population isolate</article-title>. <source/>Psychiatr. Genet.
<volume>20</volume>, <fpage>179</fpage>–<lpage>183</lpage>. <pub-id pub-id-type="doi">10.1097/YPG.0b013e32833a215a</pub-id><pub-id pub-id-type="pmid">20431429</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirschtritt</surname><given-names>M. E.</given-names></name><name><surname>Lee</surname><given-names>P. C.</given-names></name><name><surname>Pauls</surname><given-names>D. L.</given-names></name><name><surname>Dion</surname><given-names>Y.</given-names></name><name><surname>Grados</surname><given-names>M. A.</given-names></name><name><surname>Illmann</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome</article-title>. <source/>JAMA Psychiatry
<volume>72</volume>, <fpage>325</fpage>–<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2014.2650</pub-id><pub-id pub-id-type="pmid">25671412</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoekstra</surname><given-names>P. J.</given-names></name><name><surname>Dietrich</surname><given-names>A.</given-names></name><name><surname>Edwards</surname><given-names>M. J.</given-names></name><name><surname>Elamin</surname><given-names>I.</given-names></name><name><surname>Martino</surname><given-names>D.</given-names></name></person-group> (<year>2013</year>). <article-title>Environmental factors in Tourette syndrome</article-title>. <source/>Neurosci. Biobehav. Rev.
<volume>37</volume>, <fpage>1040</fpage>–<lpage>1049</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2012.10.010</pub-id><pub-id pub-id-type="pmid">23092654</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalanithi</surname><given-names>P. S. A.</given-names></name><name><surname>Zheng</surname><given-names>W.</given-names></name><name><surname>Kataoka</surname><given-names>Y.</given-names></name><name><surname>DiFiglia</surname><given-names>M.</given-names></name><name><surname>Grantz</surname><given-names>H.</given-names></name><name><surname>Saper</surname><given-names>C. B.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>102</volume>, <fpage>13307</fpage>–<lpage>13312</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0502624102</pub-id><pub-id pub-id-type="pmid">16131542</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karagiannidis</surname><given-names>I.</given-names></name><name><surname>Dehning</surname><given-names>S.</given-names></name><name><surname>Sandor</surname><given-names>P.</given-names></name><name><surname>Tarnok</surname><given-names>Z.</given-names></name><name><surname>Rizzo</surname><given-names>R.</given-names></name><name><surname>Wolanczyk</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Support of the histaminergic hypothesis in Tourette syndrome: association of the histamine decarboxylase gene in a large sample of families</article-title>. <source/>J. Med. Genet.
<volume>50</volume>, <fpage>760</fpage>–<lpage>764</lpage>. <pub-id pub-id-type="doi">10.1136/jmedgenet-2013-101637</pub-id><pub-id pub-id-type="pmid">23825391</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karagiannidis</surname><given-names>I.</given-names></name><name><surname>Rizzo</surname><given-names>R.</given-names></name><name><surname>Tarnok</surname><given-names>Z.</given-names></name><name><surname>Wolanczyk</surname><given-names>T.</given-names></name><name><surname>Hebebrand</surname><given-names>J.</given-names></name><name><surname>Nöthen</surname><given-names>M. M.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Replication of association between a SLITRK1 haplotype and Tourette Syndrome in a large sample of families</article-title>. <source/>Mol. Psychiatry
<volume>17</volume>, <fpage>665</fpage>–<lpage>668</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2011.151</pub-id><pub-id pub-id-type="pmid">22083730</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katuwawela</surname><given-names>I.</given-names></name></person-group> (<year>2012</year>). <article-title>Good response to clonidine in tourette syndrome associated with chromosomal translocation involving the IMMP2L gene</article-title>. <source/>J. Neuropsychiatry Clin. Neurosci.
<volume>24</volume>:<fpage>E17</fpage>. <pub-id pub-id-type="doi">10.1176/appi.neuropsych.11010032</pub-id><pub-id pub-id-type="pmid">22450629</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kroisel</surname><given-names>P. M.</given-names></name><name><surname>Petek</surname><given-names>E.</given-names></name><name><surname>Emberger</surname><given-names>W.</given-names></name><name><surname>Windpassinger</surname><given-names>C.</given-names></name><name><surname>Wladika</surname><given-names>W.</given-names></name><name><surname>Wagner</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Candidate region for Gilles de la Tourette syndrome at 7q31</article-title>. <source/>Am. J. Med. Genet.
<volume>101</volume>, <fpage>259</fpage>–<lpage>261</lpage>. <pub-id pub-id-type="doi">10.1002/1096-8628(20010701)101:3&lt;259::AID-AJMG1374&gt;3.0.CO;2-#</pub-id><pub-id pub-id-type="pmid">11424142</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurlan</surname><given-names>R.</given-names></name><name><surname>Eapen</surname><given-names>V.</given-names></name><name><surname>Stern</surname><given-names>J.</given-names></name><name><surname>McDermott</surname><given-names>M. P.</given-names></name><name><surname>Robertson</surname><given-names>M. M.</given-names></name></person-group> (<year>1994</year>). <article-title>Bilineal transmission in Tourette's syndrome families</article-title>. <source/>Neurology
<volume>44</volume>, <fpage>2336</fpage>–<lpage>2342</lpage>. <pub-id pub-id-type="pmid">7991122</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>S.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Nguyen</surname><given-names>T.</given-names></name><name><surname>Messier</surname><given-names>T. L.</given-names></name><name><surname>Brann</surname><given-names>M.</given-names></name><name><surname>Comings</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>1996</year>). <article-title>A serotonin receptor gene (5HT1A) variant found in a Tourette's syndrome patient</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>219</volume>, <fpage>853</fpage>–<lpage>858</lpage>. <pub-id pub-id-type="pmid">8645269</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawson-Yuen</surname><given-names>A.</given-names></name><name><surname>Saldivar</surname><given-names>J.-S.</given-names></name><name><surname>Sommer</surname><given-names>S.</given-names></name><name><surname>Picker</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Familial deletion within NLGN4 associated with autism and Tourette syndrome</article-title>. <source/>Eur. J. Hum. Genet.
<volume>16</volume>, <fpage>614</fpage>–<lpage>618</lpage>. <pub-id pub-id-type="doi">10.1038/sj.ejhg.5202006</pub-id><pub-id pub-id-type="pmid">18231125</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>C. C.</given-names></name><name><surname>Chou</surname><given-names>I.-C.</given-names></name><name><surname>Tsai</surname><given-names>C.-H.</given-names></name><name><surname>Wang</surname><given-names>T.-R.</given-names></name><name><surname>Li</surname><given-names>T.-C.</given-names></name><name><surname>Tsai</surname><given-names>F.-J.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Dopamine receptor D2 gene polymorphisms are associated in Taiwanese children with Tourette syndrome</article-title>. <source/>Pediatr. Neurol.
<volume>33</volume>, <fpage>272</fpage>–<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2005.05.005</pub-id><pub-id pub-id-type="pmid">16194726</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lei</surname><given-names>J.</given-names></name><name><surname>Deng</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Su</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>H.</given-names></name><name><surname>Liang</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Mutation screening of the HDC gene in Chinese Han patients with Tourette syndrome</article-title>. <source/>Am. J. Med. Genet. B Neuropsychiatr. Genet.
<volume>159B</volume>, <fpage>72</fpage>–<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.32003</pub-id><pub-id pub-id-type="pmid">22095709</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maestrini</surname><given-names>E.</given-names></name><name><surname>Pagnamenta</surname><given-names>A. T.</given-names></name><name><surname>Lamb</surname><given-names>J. A.</given-names></name><name><surname>Bacchelli</surname><given-names>E.</given-names></name><name><surname>Sykes</surname><given-names>N. H.</given-names></name><name><surname>Sousa</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>High-density SNP association study and copy number variation analysis of the AUTS1 and AUTS5 loci implicate the IMMP2L-DOCK4 gene region in autism susceptibility</article-title>. <source/>Mol. Psychiatry
<volume>15</volume>, <fpage>954</fpage>–<lpage>968</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2009.34</pub-id><pub-id pub-id-type="pmid">19401682</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martino</surname><given-names>D.</given-names></name><name><surname>Dale</surname><given-names>R. C.</given-names></name><name><surname>Gilbert</surname><given-names>D. L.</given-names></name><name><surname>Giovannoni</surname><given-names>G.</given-names></name><name><surname>Leckman</surname><given-names>J. F.</given-names></name></person-group> (<year>2009</year>). <article-title>Immunopathogenic mechanisms in tourette syndrome: a critical review</article-title>. <source/>Mov. Disord.
<volume>24</volume>, <fpage>1267</fpage>–<lpage>1279</lpage>. <pub-id pub-id-type="doi">10.1002/mds.22504</pub-id><pub-id pub-id-type="pmid">19353683</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathews</surname><given-names>C. A.</given-names></name><name><surname>Grados</surname><given-names>M. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Familiality of Tourette syndrome, obsessive-compulsive disorder, and attention-deficit/hyperactivity disorder: heritability analysis in a large sib-pair sample</article-title>. <source/>J. Am. Acad. Child Adolesc. Psychiatry
<volume>50</volume>, <fpage>46</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaac.2010.10.004</pub-id><pub-id pub-id-type="pmid">21156269</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathews</surname><given-names>C. A.</given-names></name><name><surname>Scharf</surname><given-names>J. M.</given-names></name><name><surname>Miller</surname><given-names>L. L.</given-names></name><name><surname>Macdonald-Wallis</surname><given-names>C.</given-names></name><name><surname>Lawlor</surname><given-names>D. A.</given-names></name><name><surname>Ben-Shlomo</surname><given-names>Y.</given-names></name></person-group> (<year>2014</year>). <article-title>Association between pre- and perinatal exposures and Tourette syndrome or chronic tic disorder in the ALSPAC cohort</article-title>. <source/>Br. J. Psychiatry
<volume>204</volume>, <fpage>40</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1192/bjp.bp.112.125468</pub-id><pub-id pub-id-type="pmid">24262815</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGrath</surname><given-names>L. M.</given-names></name><name><surname>Yu</surname><given-names>D.</given-names></name><name><surname>Marshall</surname><given-names>C.</given-names></name><name><surname>Davis</surname><given-names>L. K.</given-names></name><name><surname>Thiruvahindrapuram</surname><given-names>B.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Copy number variation in obsessive-compulsive disorder and tourette syndrome: a cross-disorder study</article-title>. <source/>J. Am. Acad. Child Adolesc. Psychiatry
<volume>53</volume>, <fpage>910</fpage>–<lpage>919</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaac.2014.04.022</pub-id><pub-id pub-id-type="pmid">25062598</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miranda</surname><given-names>D. M.</given-names></name><name><surname>Wigg</surname><given-names>K.</given-names></name><name><surname>Kabia</surname><given-names>E. M.</given-names></name><name><surname>Feng</surname><given-names>Y.</given-names></name><name><surname>Sandor</surname><given-names>P.</given-names></name><name><surname>Barr</surname><given-names>C. L.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Association of SLITRK1 to Gilles de la Tourette Syndrome</article-title>. <source/>Am. J. Med. Genet. B Neuropsychiatr. Genet.
<volume>150B</volume>, <fpage>483</fpage>–<lpage>486</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.30840</pub-id><pub-id pub-id-type="pmid">18698576</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mössner</surname><given-names>R.</given-names></name><name><surname>Müller-Vahl</surname><given-names>K. R.</given-names></name><name><surname>Döring</surname><given-names>N.</given-names></name><name><surname>Stuhrmann</surname><given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>Role of the novel tryptophan hydroxylase-2 gene in Tourette syndrome</article-title>. <source/>Mol. Psychiatry
<volume>12</volume>, <fpage>617</fpage>–<lpage>619</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4002004</pub-id><pub-id pub-id-type="pmid">17592484</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moya</surname><given-names>P. R.</given-names></name><name><surname>Dodman</surname><given-names>N. H.</given-names></name><name><surname>Timpano</surname><given-names>K. R.</given-names></name><name><surname>Rubenstein</surname><given-names>L. M.</given-names></name><name><surname>Rana</surname><given-names>Z.</given-names></name><name><surname>Fried</surname><given-names>R. L.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Rare missense neuronal cadherin gene (CDH2) variants in specific obsessive-compulsive disorder and Tourette disorder phenotypes</article-title>. <source/>Eur. J. Hum. Genet.
<volume>21</volume>, <fpage>850</fpage>–<lpage>854</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2012.245</pub-id><pub-id pub-id-type="pmid">23321619</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>T. K.</given-names></name><name><surname>Kurlan</surname><given-names>R.</given-names></name><name><surname>Leckman</surname><given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>The immunobiology of Tourette's disorder, pediatric autoimmune neuropsychiatric disorders associated with Streptococcus, and related disorders: a way forward</article-title>. <source/>J. Child Adolesc. Psychopharmacol.
<volume>20</volume>, <fpage>317</fpage>–<lpage>331</lpage>. <pub-id pub-id-type="doi">10.1089/cap.2010.0043</pub-id><pub-id pub-id-type="pmid">20807070</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nag</surname><given-names>A.</given-names></name><name><surname>Bochukova</surname><given-names>E. G.</given-names></name><name><surname>Kremeyer</surname><given-names>B.</given-names></name><name><surname>Campbell</surname><given-names>D. D.</given-names></name><name><surname>Muller</surname><given-names>H.</given-names></name><name><surname>Valencia-Duarte</surname><given-names>A. V.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>CNV analysis in Tourette syndrome implicates large genomic rearrangements in COL8A1 and NRXN1</article-title>. <source/>PLoS ONE
<volume>8</volume>:<fpage>e59061</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0059061</pub-id><pub-id pub-id-type="pmid">23533600</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Rourke</surname><given-names>J.</given-names></name><name><surname>Scharf</surname><given-names>J.</given-names></name><name><surname>Yu</surname><given-names>D.</given-names></name><name><surname>Pauls</surname><given-names>D.</given-names></name></person-group> (<year>2009</year>). <article-title>The genetics of Tourette syndrome: a review</article-title>. <source/>J. Psychosom. Res.
<volume>67</volume>, <fpage>533</fpage>–<lpage>545</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpsychores.2009.06.006</pub-id><pub-id pub-id-type="pmid">19913658</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pagnamenta</surname><given-names>A. T.</given-names></name><name><surname>Bacchelli</surname><given-names>E.</given-names></name><name><surname>de Jonge</surname><given-names>M. V.</given-names></name><name><surname>Mirza</surname><given-names>G.</given-names></name><name><surname>Scerri</surname><given-names>T. S.</given-names></name><name><surname>Minopoli</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Characterization of a family with rare deletions in CNTNAP5 and DOCK4 suggests novel risk loci for autism and dyslexia</article-title>. <source/>Biol. Psychiatry
<volume>68</volume>, <fpage>320</fpage>–<lpage>328</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2010.02.002</pub-id><pub-id pub-id-type="pmid">20346443</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pakstis</surname><given-names>A. J.</given-names></name><name><surname>Heutink</surname><given-names>P.</given-names></name><name><surname>Pauls</surname><given-names>D. L.</given-names></name><name><surname>Kurlan</surname><given-names>R.</given-names></name><name><surname>van de Wetering</surname><given-names>B. J.</given-names></name><name><surname>Leckman</surname><given-names>J. F.</given-names></name><etal></etal></person-group>. (<year>1991</year>). <article-title>Progress in the search for genetic linkage with Tourette syndrome: an exclusion map covering more than 50% of the autosomal genome</article-title>. <source/>Am. J. Hum. Genet.
<volume>48</volume>, <fpage>281</fpage>–<lpage>294</lpage>. <pub-id pub-id-type="pmid">1990837</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paschou</surname><given-names>P.</given-names></name></person-group> (<year>2013</year>). <article-title>The genetic basis of gilles de la Tourette syndrome</article-title>. <source/>Neurosci. Biobehav. Rev.
<volume>37</volume>, <fpage>1026</fpage>–<lpage>1039</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2013.01.016</pub-id><pub-id pub-id-type="pmid">23333760</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paschou</surname><given-names>P.</given-names></name><name><surname>Yu</surname><given-names>D.</given-names></name><name><surname>Gerber</surname><given-names>G.</given-names></name><name><surname>Evans</surname><given-names>P.</given-names></name><name><surname>Tsetsos</surname><given-names>F.</given-names></name><name><surname>Davis</surname><given-names>L. K.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Genetic association signal near NTN4 in Tourette syndrome</article-title>. <source/>Ann. Neurol.
<volume>76</volume>, <fpage>310</fpage>–<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1002/ana.24215</pub-id><pub-id pub-id-type="pmid">25042818</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>C.</given-names></name><name><surname>Cooper-Charles</surname><given-names>L.</given-names></name><name><surname>McMullan</surname><given-names>D. J.</given-names></name><name><surname>Walker</surname><given-names>J. M.</given-names></name><name><surname>Davison</surname><given-names>V.</given-names></name><name><surname>Morton</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Translocation breakpoint at 7q31 associated with tics: further evidence for IMMP2L as a candidate gene for Tourette syndrome</article-title>. <source/>Eur. J. Hum. Genet.
<volume>19</volume>, <fpage>634</fpage>–<lpage>639</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2010.238</pub-id><pub-id pub-id-type="pmid">21386874</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pauls</surname><given-names>D. L.</given-names></name><name><surname>Fernandez</surname><given-names>T. V.</given-names></name><name><surname>Mathews</surname><given-names>C.</given-names></name><name><surname>State</surname><given-names>M. W.</given-names></name><name><surname>Scharf</surname><given-names>J. M.</given-names></name></person-group> (<year>2014</year>). <article-title>The inheritance of Tourette disorder: a review</article-title>. <source/>J. Obsessive Compuls. Relat. Disord.
<volume>3</volume>, <fpage>380</fpage>–<lpage>385</lpage>. <pub-id pub-id-type="doi">10.1016/j.jocrd.2014.06.003</pub-id><pub-id pub-id-type="pmid">25506544</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petek</surname><given-names>E.</given-names></name><name><surname>Schwarzbraun</surname><given-names>T.</given-names></name><name><surname>Noor</surname><given-names>A.</given-names></name><name><surname>Patel</surname><given-names>M.</given-names></name><name><surname>Nakabayashi</surname><given-names>K.</given-names></name><name><surname>Choufani</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Molecular and genomic studies of IMMP2L and mutation screening in autism and Tourette syndrome</article-title>. <source/>Mol. Genet. Genomics
<volume>277</volume>, <fpage>71</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1007/s00438-006-0173-1</pub-id><pub-id pub-id-type="pmid">17043892</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petek</surname><given-names>E.</given-names></name><name><surname>Windpassinger</surname><given-names>C.</given-names></name><name><surname>Vincent</surname><given-names>J. B.</given-names></name><name><surname>Cheung</surname><given-names>J.</given-names></name><name><surname>Boright</surname><given-names>A. P.</given-names></name><name><surname>Scherer</surname><given-names>S. W.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Disruption of a novel gene (IMMP2L) by a breakpoint in 7q31 associated with Tourette syndrome</article-title>. <source/>Am. J. Hum. Genet.
<volume>68</volume>, <fpage>848</fpage>–<lpage>858</lpage>. <pub-id pub-id-type="doi">10.1086/319523</pub-id><pub-id pub-id-type="pmid">11254443</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>B. S.</given-names></name><name><surname>Thomas</surname><given-names>P.</given-names></name><name><surname>Kane</surname><given-names>M. J.</given-names></name><name><surname>Scahill</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Bronen</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Basal Ganglia volumes in patients with Gilles de la Tourette syndrome</article-title>. <source/>Arch. Gen. Psychiatry
<volume>60</volume>, <fpage>415</fpage>–<lpage>424</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.60.4.415</pub-id><pub-id pub-id-type="pmid">12695320</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poot</surname><given-names>M.</given-names></name><name><surname>Beyer</surname><given-names>V.</given-names></name><name><surname>Schwaab</surname><given-names>I.</given-names></name><name><surname>Damatova</surname><given-names>N.</given-names></name><name><surname>Van'T Slot</surname><given-names>R.</given-names></name><name><surname>Prothero</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Disruption of CNTNAP2 and additional structural genome changes in a boy with speech delay and autism spectrum disorder</article-title>. <source/>Neurogenetics
<volume>11</volume>, <fpage>81</fpage>–<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1007/s10048-009-0205-1</pub-id><pub-id pub-id-type="pmid">19582487</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rapanelli</surname><given-names>M.</given-names></name><name><surname>Frick</surname><given-names>L. R.</given-names></name><name><surname>Pogorelov</surname><given-names>V.</given-names></name><name><surname>Ota</surname><given-names>K. T.</given-names></name><name><surname>Abbasi</surname><given-names>E.</given-names></name><name><surname>Ohtsu</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Dysregulated intracellular signaling in the striatum in a pathophysiologically grounded model of Tourette syndrome</article-title>. <source/>Eur. Neuropsychopharmacol.
<volume>24</volume>, <fpage>1896</fpage>–<lpage>1906</lpage>. <pub-id pub-id-type="doi">10.1016/j.euroneuro.2014.10.007</pub-id><pub-id pub-id-type="pmid">25464894</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname><given-names>M. M.</given-names></name></person-group> (<year>2008</year>). <article-title>The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies</article-title>. <source/>J. Psychosom. Res.
<volume>65</volume>, <fpage>461</fpage>–<lpage>472</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpsychores.2008.03.006</pub-id><pub-id pub-id-type="pmid">18940377</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>S. J.</given-names></name><name><surname>He</surname><given-names>X.</given-names></name><name><surname>Willsey</surname><given-names>A. J.</given-names></name><name><surname>Ercan-Sencicek</surname><given-names>A. G.</given-names></name><name><surname>Samocha</surname><given-names>K. E.</given-names></name><name><surname>Cicek</surname><given-names>A. E.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Insights into autism spectrum disorder genomic architecture and biology from 71 risk loci</article-title>. <source/>Neuron
<volume>87</volume>, <fpage>1215</fpage>–<lpage>1233</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2015.09.016</pub-id><pub-id pub-id-type="pmid">26402605</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scharf</surname><given-names>J. M.</given-names></name><name><surname>Miller</surname><given-names>L. L.</given-names></name><name><surname>Gauvin</surname><given-names>C. A.</given-names></name><name><surname>Alabiso</surname><given-names>J.</given-names></name><name><surname>Mathews</surname><given-names>C. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Population prevalence of Tourette syndrome : a systematic review and meta-analysis</article-title>. <source/>Mov. Disord.
<volume>30</volume>, <fpage>221</fpage>–<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1002/mds.26089</pub-id><pub-id pub-id-type="pmid">25487709</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scharf</surname><given-names>J. M.</given-names></name><name><surname>Moorjani</surname><given-names>P.</given-names></name><name><surname>Fagerness</surname><given-names>J.</given-names></name><name><surname>Platko</surname><given-names>J. V.</given-names></name><name><surname>Illmann</surname><given-names>C.</given-names></name><name><surname>Galloway</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Lack of association between SLITRK1var321 and Tourette syndrome in a large family-based sample</article-title>. <source/>Neurology
<volume>70</volume>, <fpage>1495</fpage>–<lpage>1496</lpage>. <pub-id pub-id-type="doi">10.1212/01.wnl.0000296833.25484.bb</pub-id><pub-id pub-id-type="pmid">18413575</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scharf</surname><given-names>J. M.</given-names></name><name><surname>Yu</surname><given-names>D.</given-names></name><name><surname>Mathews</surname><given-names>C. A.</given-names></name><name><surname>Neale</surname><given-names>B. M.</given-names></name><name><surname>Stewart</surname><given-names>S. E.</given-names></name><name><surname>Fagerness</surname><given-names>J. A.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Genome-wide association study of Tourette's syndrome</article-title>. <source/>Mol. Psychiatry
<volume>18</volume>, <fpage>721</fpage>–<lpage>728</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2012.69</pub-id><pub-id pub-id-type="pmid">22889924</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>State</surname><given-names>M. W.</given-names></name></person-group> (<year>2011</year>). <article-title>The genetics of Tourette disorder</article-title>. <source/>Curr. Opin. Genet. Dev.
<volume>21</volume>, <fpage>302</fpage>–<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1016/j.gde.2011.01.007</pub-id><pub-id pub-id-type="pmid">21277193</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>N.</given-names></name><name><surname>Tischfield</surname><given-names>J. A.</given-names></name><name><surname>King</surname><given-names>R. A.</given-names></name><name><surname>Heiman</surname><given-names>G. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Functional evaluations of genes disrupted in patients with Tourette's disorder</article-title>. <source/>Front. psychiatry
<volume>7</volume>:<issue>11</issue>. <pub-id pub-id-type="doi">10.3389/fpsyt.2016.00011</pub-id><pub-id pub-id-type="pmid">26903887</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sundaram</surname><given-names>S. K.</given-names></name><name><surname>Huq</surname><given-names>A. M.</given-names></name><name><surname>Wilson</surname><given-names>B. J.</given-names></name><name><surname>Chugani</surname><given-names>H. T.</given-names></name></person-group> (<year>2010</year>). <article-title>Tourette syndrome is associated with recurrent exonic copy number variants</article-title>. <source/>Neurology
<volume>74</volume>, <fpage>1583</fpage>–<lpage>1590</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e3181e0f147</pub-id><pub-id pub-id-type="pmid">20427753</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swain</surname><given-names>J. E.</given-names></name><name><surname>Scahill</surname><given-names>L.</given-names></name><name><surname>Lombroso</surname><given-names>P. L.</given-names></name><name><surname>King</surname><given-names>R. A.</given-names></name><name><surname>Leckman</surname><given-names>J. F.</given-names></name></person-group> (<year>2007</year>). <article-title>Tourette syndrome and tic disorders: a decade of progress</article-title>. <source/>J. Am. Acad. Child Adolesc. Psychiatry
<volume>46</volume>, <fpage>947</fpage>–<lpage>968</lpage>. <pub-id pub-id-type="doi">10.1097/chi.0b013e318068fbcc</pub-id><pub-id pub-id-type="pmid">17667475</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swedo</surname><given-names>S. E.</given-names></name><name><surname>Leonard</surname><given-names>H. L.</given-names></name><name><surname>Garvey</surname><given-names>M.</given-names></name><name><surname>Mittleman</surname><given-names>B.</given-names></name><name><surname>Allen</surname><given-names>A. J.</given-names></name><name><surname>Perlmutter</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>1998</year>). <article-title>Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases</article-title>. <source/>Am. J. Psychiatry
<volume>155</volume>, <fpage>264</fpage>–<lpage>271</lpage>. <pub-id pub-id-type="doi">10.1176/ajp.155.2.264</pub-id><pub-id pub-id-type="pmid">9464208</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarnok</surname><given-names>Z.</given-names></name><name><surname>Ronai</surname><given-names>Z.</given-names></name><name><surname>Gervai</surname><given-names>J.</given-names></name><name><surname>Kereszturi</surname><given-names>E.</given-names></name><name><surname>Gadoros</surname><given-names>J.</given-names></name><name><surname>Sasvari-Szekely</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Dopaminergic candidate genes in Tourette syndrome: association between tic severity and 3′ UTR polymorphism of the dopamine transporter gene</article-title>. <source/>Am. J. Med. Genet. Part B Neuropsychiatr. Genet.
<volume>144</volume>, <fpage>900</fpage>–<lpage>905</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.30517</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>TSAICG</collab></person-group> (<year>2007</year>). <article-title>Genome scan for tourette disorder in affected-sibling-pair and multigenerational families</article-title>. <source/>Am. J. Hum. Genet.
<volume>80</volume>, <fpage>265</fpage>–<lpage>272</lpage>. <pub-id pub-id-type="doi">10.1086/511052</pub-id><pub-id pub-id-type="pmid">17304708</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verkerk</surname><given-names>A.</given-names></name><name><surname>Mathews</surname><given-names>C. A.</given-names></name><name><surname>Joosse</surname><given-names>M.</given-names></name><name><surname>Eussen</surname><given-names>B. B. H. J.</given-names></name><name><surname>Heutink</surname><given-names>P.</given-names></name><name><surname>Oostra</surname><given-names>B. B. A.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive comulsive disorder</article-title>. <source/>Genomics
<volume>82</volume>, <fpage>1</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/S0888-7543(03)00097-1</pub-id><pub-id pub-id-type="pmid">12809671</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willsey</surname><given-names>A. J.</given-names></name><name><surname>Sanders</surname><given-names>S. J.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Dong</surname><given-names>S.</given-names></name><name><surname>Tebbenkamp</surname><given-names>A. T.</given-names></name><name><surname>Muhle</surname><given-names>R. A.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism</article-title>. <source/>Cell
<volume>155</volume>, <fpage>997</fpage>–<lpage>1007</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2013.10.020</pub-id><pub-id pub-id-type="pmid">24267886</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>D. Y.</given-names></name><name><surname>Gause</surname><given-names>C. D.</given-names></name><name><surname>Leckman</surname><given-names>J. F.</given-names></name><name><surname>Singer</surname><given-names>H. S.</given-names></name></person-group> (<year>2007</year>). <article-title>Frontal dopaminergic abnormality in Tourette syndrome: a postmortem analysis</article-title>. <source/>J. Neurol. Sci.
<volume>255</volume>, <fpage>50</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2007.01.069</pub-id><pub-id pub-id-type="pmid">17337006</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>D.</given-names></name><name><surname>Mathews</surname><given-names>C. A.</given-names></name><name><surname>Scharf</surname><given-names>J. M.</given-names></name><name><surname>Neale</surname><given-names>B. M.</given-names></name><name><surname>Davis</surname><given-names>L. K.</given-names></name><name><surname>Gamazon</surname><given-names>E. R.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD</article-title>. <source/>Am. J. Psychiatry
<volume>172</volume>, <fpage>82</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2014.13101306</pub-id><pub-id pub-id-type="pmid">25158072</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zilhão</surname><given-names>N. R.</given-names></name><name><surname>Padmanabhuni</surname><given-names>S. S.</given-names></name><name><surname>Pagliaroli</surname><given-names>L.</given-names></name><name><surname>Barta</surname><given-names>C.</given-names></name><name><surname>Smit</surname><given-names>D. J. A.</given-names></name><name><surname>Cath</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Epigenome-wide association study of tic disorders</article-title>. <source/>Twin Res. Hum. Genet.
<volume>18</volume>, <fpage>699</fpage>–<lpage>709</lpage>. <pub-id pub-id-type="doi">10.1017/thg.2015.72</pub-id><pub-id pub-id-type="pmid">26499864</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimprich</surname><given-names>A.</given-names></name><name><surname>Hatala</surname><given-names>K.</given-names></name><name><surname>Riederer</surname><given-names>F.</given-names></name><name><surname>Stogmann</surname><given-names>E.</given-names></name><name><surname>Aschauer</surname><given-names>H. N.</given-names></name><name><surname>Stamenkovic</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Sequence analysis of the complete SLITRK1 gene in Austrian patients with Tourette's disorder</article-title>. <source/>Psychiatr. Genet.
<volume>18</volume>, <fpage>308</fpage>–<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1097/YPG.0b013e3283060f6f</pub-id><pub-id pub-id-type="pmid">19018236</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>